Increased risk of inflammatory bowel disease among patients treated with rituximab in Iceland from 2001 to 2018. Kristjansson VB, Lund SH, Grondal G, Sveinsdottir SV, et al. Scand J Gastroenterol 2020 Dec 5:1-7. doi: 10.1080/00365521.2020.1854847.

Read + Share

Amedeo Smart

Independent Medical Education

Kristjansson VB, Lund SH, Grondal G, Sveinsdottir SV, et al. Increased risk of inflammatory bowel disease among patients treated with rituximab in Iceland from 2001 to 2018. Scand J Gastroenterol 2020 Dec 5:1-7. doi: 10.1080/00365521.2020.1854847.
PMID: 33280485